|
Melanoma Research Studies
ADJUVANT
E1697 Phase
III Randomized Study of Four Weeks High Dose IFN-a2b in Stage T2b
N0,
T3a-b,
T4a-b
N0,
and T1-4
N1a ,2a, 3 (microscopic) Melanoma
METASTATIC
N0879 A
Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, with or
without Everolimus for Therapy of Metastatic Malignant Melanoma
|